TR200100583T2 - Beyin tümörü tedavisinde kullanılmak üzere aljinat kapsülleri. - Google Patents

Beyin tümörü tedavisinde kullanılmak üzere aljinat kapsülleri.

Info

Publication number
TR200100583T2
TR200100583T2 TR200100583T TR200100583T TR200100583T2 TR 200100583 T2 TR200100583 T2 TR 200100583T2 TR 200100583 T TR200100583 T TR 200100583T TR 200100583 T TR200100583 T TR 200100583T TR 200100583 T2 TR200100583 T2 TR 200100583T2
Authority
TR
Turkey
Prior art keywords
treatment
brain tumor
alginate capsules
tumors
alginate
Prior art date
Application number
TR200100583T
Other languages
English (en)
Inventor
Bjerkvig Rolf
Original Assignee
Norsk Hydro Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro Asa filed Critical Norsk Hydro Asa
Publication of TR200100583T2 publication Critical patent/TR200100583T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

CNS tümör gelisiminin bir inhibitörü olan bir molekülü ifade edebilen kapsüllenmis üretici hücreler, merkezi sinir sisteminde lokalize olarak bulunan beyin tümörleri gibi tümörlerin tedavisinde yeni bir yaklasim saglarlar.
TR200100583T 1998-08-26 1999-08-25 Beyin tümörü tedavisinde kullanılmak üzere aljinat kapsülleri. TR200100583T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO983911A NO983911D0 (no) 1998-08-26 1998-08-26 Alginatkapsler til bruk ved behandling av hjernesvulst

Publications (1)

Publication Number Publication Date
TR200100583T2 true TR200100583T2 (tr) 2001-06-21

Family

ID=19902361

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200100583T TR200100583T2 (tr) 1998-08-26 1999-08-25 Beyin tümörü tedavisinde kullanılmak üzere aljinat kapsülleri.

Country Status (16)

Country Link
US (2) US6926888B1 (tr)
EP (1) EP1105100A1 (tr)
JP (1) JP2002523445A (tr)
KR (1) KR100699286B1 (tr)
CN (1) CN1191823C (tr)
AU (1) AU760433B2 (tr)
BR (1) BR9913326A (tr)
CA (1) CA2340325A1 (tr)
IL (2) IL141501A0 (tr)
IS (1) IS5855A (tr)
NO (2) NO983911D0 (tr)
NZ (1) NZ510167A (tr)
RU (1) RU2229287C2 (tr)
TR (1) TR200100583T2 (tr)
WO (1) WO2000012066A1 (tr)
ZA (1) ZA200101464B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941505D1 (de) * 1998-02-03 2009-11-19 Ct Disease Contr & Prevention Verfahren zur herstellung rekombinanter, lipid-modifizierter psaa proteine und deren verwendung
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
KR100969516B1 (ko) * 2007-08-16 2010-07-09 경북대학교 산학협력단 세포 생존력 및 기능을 향상시키는 도우넛형 세포 캡슐의제조 방법 및 세포 치료적용
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
US5073491A (en) * 1988-12-23 1991-12-17 Hoffman-La Roche Inc. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
ATE156344T1 (de) 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
ES2125630T3 (es) 1994-07-08 1999-03-01 Baxter Int Dispositivo implantable que contiene celulas tumorales, para el tratamiento del cancer.
US6126936A (en) * 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
CN1296477C (zh) 1996-04-03 2007-01-24 罗格森研究所 含有抑制癌细胞增殖的因子的条件培养基及其制备方法
AU2674097A (en) * 1996-04-17 1997-11-07 Cytotherapeutics, Inc. Method and device for delivery of apoptosis-inducing molecules
US6027721A (en) 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
DE19638745C2 (de) * 1996-09-11 2001-05-10 Schering Ag Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
US6368612B1 (en) * 1997-12-12 2002-04-09 Biohybrid Technologies Llc Devices for cloaking transplanted cells

Also Published As

Publication number Publication date
ZA200101464B (en) 2002-05-21
BR9913326A (pt) 2001-05-15
AU5538999A (en) 2000-03-21
CA2340325A1 (en) 2000-03-09
JP2002523445A (ja) 2002-07-30
CN1320032A (zh) 2001-10-31
KR100699286B1 (ko) 2007-03-26
EP1105100A1 (en) 2001-06-13
NO20010960D0 (no) 2001-02-26
RU2229287C2 (ru) 2004-05-27
CN1191823C (zh) 2005-03-09
NO983911D0 (no) 1998-08-26
IS5855A (is) 2001-02-22
IL141501A0 (en) 2002-03-10
WO2000012066A1 (en) 2000-03-09
IL141501A (en) 2006-10-31
NO20010960L (no) 2001-04-25
US6926888B1 (en) 2005-08-09
AU760433B2 (en) 2003-05-15
US20050180960A1 (en) 2005-08-18
KR20010074851A (ko) 2001-08-09
NZ510167A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
IL127946A0 (en) Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
ZA975439B (en) New pyridyl alkane acid amides.
PL344475A1 (en) Bridged indenopyrrolocarbazoles
NO20003414D0 (no) Anvendelse av PPAR-<ypsilon> aktivatorer i dermatologi
BG104938A (en) Substituted indolinones, the production thereof and their use as medicaments
EA200101046A1 (ru) Производные индигоидных бис-индолов
EP2366712A3 (en) A tumor suppressor designated TS10Q23.3
EP1117672A4 (en) ANTISENSE MODULATION OF THE SURVIVIN EXPRESSION
ATE220679T1 (de) Porphyrine und ihre verwendung als photosensitizer
TR200100583T2 (tr) Beyin tümörü tedavisinde kullanılmak üzere aljinat kapsülleri.
BR9914907A (pt) Cápsula mineral, processo para sua preparação, e, utilização das cápsulas
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
EP1012338A4 (en) A TUMOR SUPPRESSOR NAME TS10Q23.3
YU13499A (sh) Primena 1-hidroksi-2-piridona za lečenje seboroitičnog dermatitisa
TR199700547A2 (tr) N-asetonilbenzamid fungisitler.
ATE328899T1 (de) Zellkernlokalisierendes protein für beta-catenin
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
DK1135170T3 (da) Radiokonjugation af internaliserende antistoffer
WO2003107545A3 (en) TECHNIQUES FOR IDENTIFYING COMPOUNDS FOR TREATING PATHOLOGICAL CONDITIONS
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
GB9907048D0 (en) Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
ATE291738T1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
ES2194904T3 (es) Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.
BR0016710A (pt) Pó de bisfenol fluidizado